1. 🧠 At a Glance
Linde India is India’s largest industrial gases company and a quiet monopoly in sectors like steel, pharma, and chemicals. Despite flat sales and boring growth, it’s built an OPM of 35% and remains debt-free. But with a P/E of 126 and low 5Y revenue CAGR of just 7%, the question is: How long can this compressed valuation stay inflated?
2. 🧲 Introduction — The Most Boring Multibagger You’ve Never Noticed
While everyone else chased PSU turnarounds, SME IPOs, and tech darlings, Linde India just chilled. Literally.
Because their core business is cold, compressed, cryogenic, and 100% boring.
But boring pays.
From ₹1,000 in 2018 to ₹9,300 in 2024, Linde silently became one of India’s most expensive stocks. And now that it’s back to ₹6,600 — investors are asking: is this a healthy pullback or has the helium finally leaked?
3. 🏭 Business Model — WTF Do They Even Do?
Linde India runs on three cylinders:
- 🧪 Gas & Related Products (~85% of revenue):
- Pipeline gas supply to industrial giants — think steel, chemicals, pharma
- Bulk cryogenic gas to factories via tankers
- Cylinders for smaller players in manufacturing, hospitals, etc.
- 🏥 Medical Gases (Healthcare):
- Medical oxygen, nitrous oxide, synthetic air
- Supplied to hospitals, pharma plants, and medical equipment suppliers
- In COVID years, this segment saved lives and margins
- 🛠 Project Engineering Division (PED):
- Turnkey setup of air separation units (ASUs)
- End-to-end design + install of gas plants
- High-ticket B2B orders with long gestation, but sweet margins
And their real edge?
🧪 Parent support from Linde PLC (via BOC UK) means:
- Proprietary tech
- Access to global IP
